CompletedNCT00287417

Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down Syndrome During the First Trimester

Studying Down syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Strasbourg, France
Principal Investigator
Israel Nisand, MD
Hopitaux Universitaires de Strasbourg
Intervention
echography(device)
Enrollment
20000 enrolled
Eligibility
18 years · FEMALE
Timeline
20032011

Study locations (7)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00287417 on ClinicalTrials.gov

Other trials for Down syndrome

Additional recruiting or active studies for the same condition.

See all trials for Down syndrome

← Back to all trials